For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 63,981 | |||
| General and administrative | 552,138 | |||
| Total operating expenses | 616,119 | |||
| Loss from operations | -616,119 | |||
| Other income | 14,000 | |||
| Interest income | 6 | |||
| Interest expense on loan payable | 10,001 | |||
| Non-cash interest expense on convertible notes | 73,332 | |||
| Accretion to redemption value on convertible notes | 0 | |||
| Total other income, net | -69,327 | |||
| Loss before provision for income taxes | -685,446 | |||
| Provision for income taxes | 2,400 | |||
| Net loss | -687,846 | |||
| Basic EPS | -0.1 | |||
| Diluted EPS | -0.1 | |||
| Basic Average Shares | 7,236,447 | |||
Mosaic ImmunoEngineering Inc. (CPMV)
Mosaic ImmunoEngineering Inc. (CPMV)